-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRD-4730 in Ventricular Tachycardia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRD-4730 in Ventricular Tachycardia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRD-4730 in Ventricular Tachycardia Drug Details: CRD-4730 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Vitiligo
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Vitiligo report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Vitiligo Drug Details: Afamelanotide (Scenesse) is an analog...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Acne Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Acne Vulgaris Drug Details: Afamelanotide (Scenesse) is an...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Afamelanotide Acetate in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Afamelanotide Acetate in Acute Ischemic Stroke report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Afamelanotide Acetate in Acute Ischemic Stroke Drug Details: Afamelanotide (Scenesse)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARM-210 in Ventricular Tachycardia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARM-210 in Ventricular Tachycardia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ARM-210 in Ventricular Tachycardia Drug Details: ARM-210 is under development for the...
-
Product Insights
Acquired Gene or Chromosome Alterations Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies
Acquired Gene or Chromosome Alterations Pipeline Market Report Overview Acquired Gene or Chromosome Alterations are reagents employed for genetic testing to detect cancer-causing or related alterations. The Acquired Gene or Chromosome Alterations pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Track & Monitor
Artificial Intelligence in Pharmaceuticals: DNA polymorphism detection
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s DNA polymorphism detection segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
Net Present Value Model: Aldurazyme
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Aldurazyme Drug Details Laronidase (Aldurazyme) is...
-
Product Insights
Net Present Value Model: Allelock
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Allelock Drug Details Olopatadine hydrochloride (Allelock)...
-
Product Insights
Net Present Value Model: RLYB-212
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model RLYB-212 Drug Details RLYB-212 (Human platelet...